Article
Biogeneric native and polyethylene glycol-conjugated <i>E. coli</i> asparaginases for treating children with acute lymphoblastic leukaemia
2025-10-30
Abstract excerpt
Escherichia coli asparaginases (EcASNase) available for the treatment of children with acute lymphoblastic leukaemia (ALL) are largely of suboptimal quality in low-middle income countries (LMIC) and contribute to inferior outcomes. The pharmacokinetics, activity, and immunogenicity of a native (EcASNase) and a PEGylated ASNase (PEG-EcASNase) were analysed. Biogeneric EcASNase 10,000 IU/m 2 was administered intram...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ff0ccc79-ef00-5d71-bdd9-a994a54a07c7
- DOI
- 10.1101/2025.10.28.25337165
